13F HOLDINGS REPORT
CVS HEALTH Corp
Quarter ended Q1 2023 · Filed February 10, 2023 · Accession 0000947871-23-000152
Total Value
$116.0M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES CORE HIGH DIVIDEND ETF | 46429B663 | 624,536 | $65.1M | 56.12% |
| 2 | VANGUARD WHITEHALL FDS | 921946406 | 212,832 | $23.0M | 19.85% |
| 3 | SCHWAB STRATEGIC TR US DIV | 808524797 | 297,006 | $22.4M | 19.34% |
| 4 | LUMIRADX LTD | G5709L117 | 5,352,106 | $4.8M | 4.15% |
| 5 | HEALTH CATALYST INC | HCAT | 32,273 | $343,057 | 0.30% |
| 6 | PRUDENTIAL FINANCIAL INC | PUKPF | 2,683 | $266,851 | 0.23% |